Short bio. Dr Peter Campbell is Head of the Cancer, Ageing and Somatic Mutation Programme at the Wellcome Sanger Institute, having started a Wellcome Senior Clinical Fellowship in 2010. He completed specialist training in Haematology in New Zealand and Australia in 2002. Following this, he completed a PhD at the University of Cambridge in the molecular pathogenesis of myeloproliferative disorders. Since 2007, Dr Campbell has been employed at the Cancer Genome Project, Wellcome Trust Sanger Institute.
His major interest is cancer genomics, and in particular genome-wide analyses of somatic mutations in tumours. The four major areas of interest have been:
• the discovery of new cancer genes;
• the identification of somatic mutation processes operative in tumours;
• the characterisation of patterns of cancer evolution; and
• the translation of these fundamental insights about cancer biology into better management of patients.
Further details are available at: http://www.sanger.ac.uk/people/directory/campbell-peter